![Michael K. McGarrity](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael K. McGarrity
Director Ejecutivo en MDXHEALTH SA .
Fortuna: - $ al 30/06/2024
Cargos activos de Michael K. McGarrity
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MDXHEALTH SA | Director/Miembro de la Junta | 18/02/2019 | - |
Director Ejecutivo | 18/02/2019 | - | |
LeviSense Medical, Inc. | Presidente | - | - |
MDxHealth, Inc.
![]() MDxHealth, Inc. BiotechnologyHealth Technology Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - |
Historial de carrera de Michael K. McGarrity
Antiguos cargos conocidos de Michael K. McGarrity.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Sterilis Solutions, LLC
![]() Sterilis Solutions, LLC Medical SpecialtiesHealth Technology Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA. | Director Ejecutivo | 01/06/2017 | 01/01/2018 |
NANOSPHERE, INC. | Director/Miembro de la Junta | 19/02/2013 | 01/09/2016 |
Director Ejecutivo | 13/02/2013 | 01/09/2016 | |
Presidente | 13/02/2013 | 01/09/2016 | |
Ventas & Marketing | 01/09/2005 | 01/01/2013 | |
STRYKER CORPORATION | Ventas & Marketing | 01/01/1993 | 01/01/2005 |
Formación de Michael K. McGarrity.
University of Notre Dame | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Bélgica | 2 |
Operativa
Chief Executive Officer | 4 |
Director/Board Member | 3 |
Sales & Marketing | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
MDXHEALTH SA | Health Technology |
Empresas privadas | 4 |
---|---|
Nanosphere, Inc.
![]() Nanosphere, Inc. Medical SpecialtiesHealth Technology Nanosphere, Inc. engages in the development, manufacture, and market of molecular diagnostics platform. Its platform, Verigene System, enables clinicians to identify and treat bacteria and viruses responsible for some of the most complex, costly, and deadly infectious diseases. The company was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL. | Health Technology |
Sterilis Solutions, LLC
![]() Sterilis Solutions, LLC Medical SpecialtiesHealth Technology Sterilis LLC develops regulated medical waste remediation device. It sterilizes and grinds medical waste, rendering it acceptable for disposal in regular trash as described in OSHA and State regulations. The company was founded by Jeffrey H. Bell in June 2011 and is headquartered in Boxborough, MA. | Health Technology |
LeviSense Medical, Inc. | |
MDxHealth, Inc.
![]() MDxHealth, Inc. BiotechnologyHealth Technology Part of MDxHealth SA, MDxHealth, Inc. is a precision diagnostics company that specializes in providing personalized molecular diagnostic information for the diagnosis and treatment of cancer. The company is based in Irvine, CA, with laboratory operations in Nijmegen and headquarters in Herstal, Belgium. The company's tests are based on proprietary genetic and epigenetic technologies that assist physicians in diagnosing urologic cancers and predicting recurrence risk. MDxHealth's ConfirmMDx for Prostate Cancer test helps to rule-in high-risk men who have had a previous negative biopsy result and rule-out otherwise cancer-free men from undergoing unnecessary repeat biopsies and screening procedures. | Health Technology |
- Bolsa de valores
- Insiders
- Michael K. McGarrity
- Experiencia